Press Releases Keyword Search Year None201920182017 June 3, 2017 Anti-tumor Activity Observed in Phase 1 Trial of Novel P53-Targeting Drug ALRN-6924 May 18, 2017 Aileron Therapeutics Announces Oral Presentation at ASCO on ALRN-6924 Targeting p53 Pagination First page « first Previous page ‹ previous Page 1 Page 2 Page 3 Page 4 Page 5 Current page 6
